Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study)

Schaefer, Guido; Hoffmann, Christian; Arasteh, Keikawus; Schuermann, Dirk; Stephan, Christoph; Jensen, Bjoern; Stoll, Matthias; Bogner, Johannes R.; Faetkenheuer, Gerd; Rockstroh, Juergen; Klinker, Hartwig; Haerter, Georg; Stoehr, Albrecht; Degen, Olaf; Freiwald, Eric; Huefner, Anja; Jordan, Sabine; Zur Wiesch, Julian Schulze; Addo, Marylyn; Lohse, Ansgar W.; van Lunzen, Jan; Schmiedel, Stefan; IDEAL Study Grp

Erstveröffentlichung

2019

Authors

Schaefer, Guido

Hoffmann, Christian

Arasteh, Keikawus

Schuermann, Dirk

Stephan, Christoph

et al.

Wissenschaftlicher Artikel

Published in

AIDS Research and Therapy ; 16 (2019), 1. - Art.-Nr. 34. - ISSN 1742-6405

Link to publication

https://dx.doi.org/10.1186/s12981-019-0250-2

Institutions

UKU. Klinik für Innere Medizin III

Fachliche Einordnung

[Freie Tags]: Late presentation, Opportunistic infections, Pneumocystis jirovecii, PCP, Cerebral toxoplasmosis HIV, Diagnosis, Treatment, LATE DIAGNOSIS, INITIATION, START, CONSEQUENCES, INDIVIDUALS, COMBINATION, EFFICACY, EARLIER, SAFETY, TIME
DDC 610 / Medicine & health

Metadata

Show full item record